Jill Brufsky

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events

Julie R. Brahmer, Hamzah Abu‐Sbeih, Paolo A. Ascierto et al. · Journal for ImmunoTherapy of Cancer · 2021 · 826 citations · Full text

Pharmacy, Immunology, Oncology +17

Primary Care Providers’ Knowledge, Attitudes, Beliefs, and Practices Regarding Their Preparedness to Provide Cancer Survivorship Care

Emily Geramita, Ira R. Parker, Jill Brufsky et al. · Journal of Cancer Education · 2019 · 33 citations · Full text

Medicine, Family Medicine, Oncology +14

Shifting Physician Prescribing to a Preferred Histamine-2-Receptor Antagonist

Jill Brufsky, Dennis Ross‐Degnan, David Calabrese et al. · Medical Care · 1998 · 31 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Effects of a personal trainer-led exercise intervention on physical activity, physical function, and quality of life of breast cancer survivors

Linda F. Wang, Yvonne L. Eaglehouse, Janette T. Poppenberg et al. · Breast Cancer · 2021 · 26 citations · Full text

Medicine, Health Promotion, Rehabilitation Medicine +17

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia

Michael Boyiadzis, Michael Bishop, Rafat Abonour et al. · Journal for ImmunoTherapy of Cancer · 2016 · 18 citations · Full text

Medicine, Hematology, Oncology +13